Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, Hiltermann TJN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B. Girard N, et al. Among authors: hiltermann tjn. J Thorac Oncol. 2023 Feb;18(2):181-193. doi: 10.1016/j.jtho.2022.10.003. Epub 2022 Oct 25. J Thorac Oncol. 2023. PMID: 36307040 Free article.
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes.
Hurkmans DP, Tamminga M, van Es B, Peters T, Karman W, van Wijck RTA, van der Spek PJ, Tauber T, Los M, van Schetsen A, Vu T, Hiltermann TJN, Schuuring E, Aerts JGJV, Chen S, Groen HJM. Hurkmans DP, et al. Among authors: hiltermann tjn. Lung Cancer. 2020 Aug;146:341-349. doi: 10.1016/j.lungcan.2020.06.008. Epub 2020 Jun 20. Lung Cancer. 2020. PMID: 32645666 Free article.
Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.
van der Geest KSM, Sandovici M, Rutgers A, Hiltermann TJN, Oosting SF, Slart RHJA, Brouwer E. van der Geest KSM, et al. Among authors: hiltermann tjn. Ann Rheum Dis. 2022 Oct;81(10):e210. doi: 10.1136/annrheumdis-2020-217381. Epub 2020 Apr 2. Ann Rheum Dis. 2022. PMID: 32241799 Free PMC article. No abstract available.
Management of immune checkpoint inhibitor-induced polymyalgia rheumatica.
van der Geest KSM, Sandovici M, Rutgers A, Hiltermann TJN, Oosting SF, Slart RHJA, Brouwer E. van der Geest KSM, et al. Among authors: hiltermann tjn. Ann Rheum Dis. 2022 Dec;81(12):e263. doi: 10.1136/annrheumdis-2020-218276. Epub 2020 Sep 4. Ann Rheum Dis. 2022. PMID: 32887684 No abstract available.
The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Rijn CJ, Terstappen LW. de Wit S, et al. Sci Rep. 2015 Jul 17;5:12270. doi: 10.1038/srep12270. Sci Rep. 2015. PMID: 26184843 Free PMC article.
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.
Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE. Bensch F, et al. Among authors: hiltermann tjn. Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26. Nat Med. 2018. PMID: 30478423 Clinical Trial.
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
Groen HJ, Sietsma H, Vincent A, Hochstenbag MM, van Putten JW, van den Berg A, Dalesio O, Biesma B, Smit HJ, Termeer A, Hiltermann TJ, van den Borne BE, Schramel FM. Groen HJ, et al. J Clin Oncol. 2011 Nov 10;29(32):4320-6. doi: 10.1200/JCO.2011.35.5214. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990410 Clinical Trial.
Air Pollution and Adenocarcinoma in Never-Smokers.
Groen HJM, Hiltermann TJN. Groen HJM, et al. Among authors: hiltermann tjn. J Thorac Oncol. 2019 May;14(5):761-763. doi: 10.1016/j.jtho.2019.02.007. J Thorac Oncol. 2019. PMID: 31027739 Free article. No abstract available.
Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.
van der Leest P, Hiddinga B, Miedema A, Aguirre Azpurua ML, Rifaela N, Ter Elst A, Timens W, Groen HJM, van Kempen LC, Hiltermann TJN, Schuuring E. van der Leest P, et al. Among authors: hiltermann tjn. Mol Oncol. 2021 Nov;15(11):2910-2922. doi: 10.1002/1878-0261.13090. Epub 2021 Sep 25. Mol Oncol. 2021. PMID: 34449963 Free PMC article.
92 results